Carole Longson, director of NICE's health technology evaluation centre, said it was now clear that Gilenya was a cost-effective option for these patients, provided Novartis supplied the drug at the discounted price it previously suggested.
A NICE spokeswoman said the size of the discount remained confidential. The list price for 28 capsules is 1,470 pounds ($2,300) or just over 19,000 pounds per person for a year.
Friday, March 16, 2012
Anyone know the "confidential" Gilenya price?